Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Compston

Coles

. Multiple sclerosis. Lancet 2002; 359: 1221–31.

Hyland

Rudick

. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs Current Opinion in Neurology 2011; 24: 255–261.

Filippi

Agosta

. Imaging biomarkers in multiple sclerosis. J Magn Reson Imaging 2010; 31: 770–788.

Daumer

Neuhaus

Morrissey

. MRI as an outcome in multiple sclerosis clinical trials. Neurology 2009; 72: 705–711.

Moraal

Wattjes

Geurts

. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology 2010; 255: 154–163.

Jacobs

Cookfair

Rudick

. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). Mult Scler 1995; 1: 118–135.

Schwid

Goodman

Mattson

. The measurement of ambulatory impairment in multiple sclerosis. Neurology 1997; 49: 1419–1424.

Tumani

Hartung

Hemmer

. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis 2009; 35(2): 117–127.

Evans

Armon

Frohman

. Assessment: prevention of postlumbar puncture headaches: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 909–914.

10.

Giovannoni

. Lumbar puncture for clinical trials in MS. http://multiple-sclerosis-research.blogspot.com/

11.

Strupp

Schueler

Straube

. Atraumatic Sprotte needle reduces the incidence of post-lumbar puncture headaches. Neurology 2001; 57: 2310–2312.

12.

Peskind

Riekse

Quinn

. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord 2005; 19(4): 220–225.